Andala

andala.life ↗ ·Madrid ·Pre-seed

Andala is a Spanish microbiota-focused wellness brand based in Madrid that sells science-backed nutraceutical supplements (e.g. DeBloat, Cortisol Calm, GlucoGuard, Triple Magnesio) targeting digestion, stress and metabolic health via D2C e-commerce. It was launched in April 2025 through Pascual Innoventures' corporate "company building" venture studio and positions itself as a microbiota-science company rather than a traditional supplement brand, citing clinical studies and patented probiotic strains behind its formulas.

Founded

2023

Founders

Total funds raised

—

Rounds

Investors

SectorsHealthtech & Bio, Consumer, Foodtech & Agtech Start-up MapHealthtech & Bio › Consumer & telehealth services

Suggest a correction

Founders

Alfonso De Juan Von Wichmann

Co-founder & CEO

Gabriel Torres Pascual

Co-founder & President (also CEO of Pascual Innoventures)

Also at Pascual Innoventures

Global models 5

Viome Life Sciences

United States · www.viome.com ↗

Microbiome testing company that sells personalized supplements based on gut microbiota analysis, closely matching Andala's science-based microbiota-to-product model.

$225MComparable

Seed Health

United States · seed.com ↗

Probiotic/microbiome science company selling clinically-backed synbiotic supplements direct-to-consumer, same evidence-based microbiota positioning as Andala.

$180MComparable

Ritual

United States · ritual.com ↗

D2C clean-label vitamin and supplement brand emphasizing ingredient transparency and clinical evidence, same DTC nutraceutical business model.

$140MComparable

ZOE

United Kingdom · joinzoe.com ↗

Personalized nutrition company built around gut microbiome science and metabolic health, the closest European comparable to Andala's model.

$130MComparable

Care/of

United States · www.careof.com ↗

Subscription D2C personalized vitamin and supplement brand later acquired by Bayer, matching Andala's personalized-supplement e-commerce approach.

$63MComparable

In the same niche 60 others

See all in the Start-ups Map →

Venture Debt · €24.1M

Therapyside

Madrid

Series A · €14.5M

+54 more →

Notes: Most funded first

Investors 1

Open as list →

Pascual Innoventures

pascualinnoventures.com

Investor Spain

Funding rounds

No announced rounds on record.

News 2

Open as list →

Published	Article
2026-05-14	Andala pone la microbiota en el centro del bienestar moderno con su nueva propuesta de salud digestiva ↗ Nutrasalud 2026-05-14
2025-04-24	Pascual enfrenta la salud de la microbiota a través del "company building" Andala Nutrición ↗ Alimarket 2025-04-24